Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients

NCT07237451 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

CKD - Chronic Kidney Disease
Heart Failure Preserved Ejection Fraction
SGLT2 Inhibitors
Diabetes (DM)

Interventions

DIAGNOSTIC_TEST: Arterial stiffness
DIAGNOSTIC_TEST: Echocardiography
OTHER: Biomarkers determination
OTHER: NMR metabolomics and uremic toxins mapping

Sponsor

Grigore T. Popa University of Medicine and Pharmacy

Collaborators

[object Object]
[object Object]